Catalogue identityPreview · noindex

Restylane Skinboosters Vital Lidocaine

Galderma

This is the Restylane Skinboosters Vital Lidocaine identity captured in the dated Aesthetic Pass operational catalogue snapshot. Product-specific source verification is available at family level only.

Evidence status: Catalogue identity · family sources available

Identity record

What is recorded

v2026.08.15.1
Record type
Operational catalogue identity
Recorded maker
Galderma
Classification
Skin booster / biostimulator
Material identity
Not recorded in this snapshot
Snapshot date
14 August 2026

Manufacturer and category are catalogue fields. They are not, by themselves, a regulatory classification or verification of the exact marketed presentation.

Family evidence available

This identity maps to Restylane

The family profile provides aliases and official family-level sources. Those sources do not automatically verify this exact variant, formulation, label, or market status.

Open family profile

Provenance

Family-level sources

3 sources · checked 14 August 2026

These sources support the linked family profile, not every property of this exact catalogue identity.

  1. Manufacturer

    1. Restylane science and technology

    Galderma · United States

    Open source ↗

    Supports: Restylane family identity, named technologies, and hyaluronic-acid material class.

  2. Regulator

    2. FDA-approved dermal fillers

    U.S. Food and Drug Administration · United States

    Open source ↗

    Supports: Regulatory-method context and the requirement to verify individual filler records and labels.

  3. Regulator

    3. RESTYLANE injectable gel — PMA P040024

    U.S. Food and Drug Administration · United States

    Open source ↗

    Supports: The original US Restylane PMA record, Q-Med applicant identity, generic device class, and supplement history.

Use boundary

What this record does not establish

  • Regulatory statusOnly within a source's named jurisdiction; family-profile review does not establish status elsewhere.
  • Authenticity or supply chainA catalogue name cannot authenticate an individual box, lot, or seller.
  • Clinical suitabilityNo product selection, patient assessment, dose, protocol, or injection technique is provided.
  • Availability or equivalenceNames, formulations, units, and presentations can vary by market and over time.

Separate reference from record-keeping

Document the exact product and lot actually used

Aesthetic Pass records treatment identity, lot information, photos, and injection maps. The atlas itself never chooses a product or treatment.

Explore traceability